Across India's fertility clinics, a quiet financial crisis unfolds in the shadow of a long-held assumption: that infertility is a woman's burden. A new multicentre study has revealed that treating male infertility costs nearly as much as treating endometriosis, the most expensive reproductive condition studied, yet it remains almost entirely absent from public health planning. With nearly 60 percent of couples spending catastrophically on care they must finance entirely themselves, the research asks a deeper question — not merely about money, but about which suffering a society chooses to see.
The South First
· Jun 08, 2026
· health
· 6 min read
High
Sourcing: Verified
Male infertility treatment costs rival endometriosis in India, exposing hidden burden
Couples seeking infertility treatment face severe financial distress and impoverishment, with many resorting to loans and borrowing to afford care.
◉
Health & Medicine
8412 related articles
Retatrutide: Eli Lilly's Triple-Action Weight-Loss Drug Poised to Resh…
The Economic Times · 100% match
Eli Lilly Seeks FDA Approval for Tirzepatide as Weight-Loss Treatment
Interesting Engineering · 99% match
Eli Lilly's Oral GLP-1 Pill Shows Promise for Diabetes and Weight Loss
TODAY · 99% match
Eli Lilly Seeks FDA Approval for Tirzepatide as Weight Loss Drug
ScienceAlert · 99% match
Moderna's personalized mRNA melanoma vaccine shows promise in preventi…
CBS News · 99% match
Related Coverage
BBC News · Aug 25
School asbestos exposure linked to woman's death at 46, family claims
A woman died from mesothelioma at 46, likely exposed to asbestos at her Cardiff school decades earlier. Her family is su…
Future of Personal Health - · Aug 25 NGS Technology Transforms Uncertain Infections Into Actionable DiagnosesHybrid-capture NGS technology helps clinicians identify pathogens in diagnostically challenging cases by simultaneously …
The Guardian · Aug 25 Shark attack survivor Leah Stewart recalls 'monster' in first interview since losing armLeah Stewart, who lost her arm in a June shark attack at Coogee Beach, recalls the traumatic encounter in her first inte…
Education News Canada · Aug 25 Systemic racism, restrictive policies block Black Canadians from blood donationBlack Canadians face systemic barriers to blood donation despite critical need for ethnicity-matched blood for sickle ce…
Bias & Framing
⚖
Article presents balanced reporting on male infertility costs in India, though framing emphasizes correcting perceived underrepresentation of male infertility in health discourse.
Bias Direction
center-left
Confidence
MED
Corrective framing that positions male infertility as an overlooked issue deserving equal attention to female reproductive health conditions. Uses comparative cost analysis to argue for recognition parity.
often overlooked
emerging as
hidden burden
exposing
under-recognised financial burden
growing concern
Healthcare provider perspective on treatment cost drivers
Insurance industry rationale for coverage gaps
Government health policy perspective on infertility funding
Comparative international context on infertility treatment costs
Voices of male infertility patients themselves (only statistics presented)
Geopolitical Impact
🌎
Indian infertility study reveals male infertility treatment costs rival endometriosis expenses, exposing healthcare access disparities and financial burden on families with minimal insurance coverage.
Escalation Risk
low
Confidence
MED
India
South Asia
This reflects India's healthcare system fragmentation where reproductive health services remain privatized and unequally accessible. The findings may shift policy attention toward male infertility, historically marginalized in public health discourse, potentially influencing insurance coverage debates and government health program priorities in South Asia.
Similar to how developed nations gradually expanded infertility coverage in insurance schemes (1980s-2000s), India faces pressure to integrate reproductive health into public systems as economic burden becomes quantifiable.
Economic Lens
📈
Indian study reveals male infertility treatment costs ₹16,566 annually with 59% of couples facing catastrophic health spending, exposing significant gaps in insurance coverage and public health support.
Market Signal
mixed
Confidence
HIGH
Healthcare/Fertility Services
Insurance/Health Insurance
Pharmaceuticals
Medical Devices
Public Health Policy
Household Finance
Households face severe financial distress with nearly 60% experiencing catastrophic health expenditure on infertility treatment. Out-of-pocket costs of ₹11,317-₹16,943 annually create significant burden on middle and lower-income families, potentially delaying or preventing treatment access and impacting family planning decisions.
Urgent need for: (1) Expansion of infertility treatment coverage under public health schemes and insurance policies; (2) Regulatory framework to standardize and control fertility treatment costs; (3) Recognition of male infertility in reproductive health programs; (4) Subsidies or financial assistance mechanisms for economically disadvantaged couples; (5) Integration of fertility care into mainstream healthcare.